The PML-associated protein DEK regulates the balance of H3.3 loading on chromatin and is important for telomere integrity

Genome Research

Volumn 24, Issue 10, 2014, Pages 1584-1594

  Ivanauskiene, Kristina ^a   Delbarre, Erwan ^a   McGhie, James D ^b   Kuntziger, Thomas ^a   Wong, Lee H ^b   Collas, Philippe ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; DEK PROTEIN; HISTONE H3; HISTONE H3.3; ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; UNCLASSIFIED DRUG; CHROMATIN; DEK PROTEIN, HUMAN; DEK PROTEIN, MOUSE; DNA BINDING PROTEIN; HISTONE; NONHISTONE PROTEIN;

ANIMAL CELL; ARTICLE; CELL FRACTIONATION; CELL NUCLEUS INCLUSION BODY; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOME ARM; EMBRYONIC STEM CELL; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; GENETIC TRANSFECTION; HETEROCHROMATIN; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN DEPLETION; PROTEIN MOTIF; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATIC CELL; TELOMERE; ANIMAL; CELL LINE; CHROMATIN ASSEMBLY AND DISASSEMBLY; METABOLISM;

ANIMALS; CELL LINE; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; EMBRYONIC STEM CELLS; HISTONES; HUMANS; MICE; ONCOGENE PROTEINS; TELOMERE;

EID: 84924857020     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.173831.114     Document Type: Article

References (53)

1. Adam S, Polo SE, Almouzni G. 2013. Transcription recovery after DNA damage requires chromatin priming by the H3.3 histone chaperone HIRA. Cell 155: 94-106.
2. Alexiadis V, Waldmann T, Andersen J, Mann M, Knippers R, Gruss C. 2000. The protein encoded by the proto-oncogene DEK changes the topology of chromatin and reduces the efficiency of DNA replication in a chromatin-specific manner. Genes Dev 14: 1308-1312.
3. Antao JM, Mason JM, Dejardin J, Kingston RE. 2012. Protein landscape at Drosophila melanogaster telomere-associated sequence repeats. Mol Cell Biol 32: 2170-2182.
4. Argentaro A, Yang JC, Chapman L, Kowalczyk MS, Gibbons RJ, Higgs DR, Neuhaus D, Rhodes D. 2007. Structural consequences of disease-causing mutations in the ATRX-DNMT3-DNMT3L (ADD) domain of the chromatin-associated protein ATRX. Proc Natl Acad Sci 104: 11939-11944.
5. Banaszynski LA, Wen D, Dewell S, Whitcomb SJ, Lin M, Diaz N, Elsasser SJ, Chapgier A, Goldberg AD, Canaani E, et al. 2013. Hira-dependent histone H3.3 deposition facilitates PRC2 recruitment at developmental loci in ES cells. Cell 155: 107-120.
6. Benetti R, Gonzalo S, Jaco I, Schotta G, Klatt P, Jenuwein T, Blasco MA. 2007. Suv4-20h deficiency results in telomere elongation and derepression of telomere recombination. J Cell Biol 178: 925-936.
7. Benetti R, Gonzalo S, Jaco I, Munoz P, Gonzalez S, Schoeftner S, Murchison E, Andl T, Chen T, Klatt P, et al. 2008. A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases. Nat Struct Mol Biol 15: 998.
8. Bernardi R, Pandolfi PP. 2007. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol 8: 1006-1016.
9. Bohm F, Kappes F, Scholten I, Richter N, Matsuo H, Knippers R, Waldmann T. 2005. The SAF-box domain of chromatin protein DEK. Nucleic Acids Res 33: 1101-1110.
10. Broxmeyer HE, Mor-Vaknin N, Kappes F, Legendre M, Saha AK, Ou X, O'Leary H, Capitano M, Cooper S, Markovitz DM. 2013. Concise review: role of DEK in stem/progenitor cell biology. Stem Cells 31: 1447-1453.
11. Chang FT, McGhie JD, Chan FL, Tang MC, Anderson MA, Mann JR, Andy Choo KH, Wong LH. 2013. PML bodies provide an important platform for the maintenance of telomeric chromatin integrity in embryonic stem cells. Nucleic Acids Res 41: 4447-4458.
12. Ching RW, Ahmed K, Boutros PC, Penn LZ, Bazett-Jones DP. 2013. Identifying gene locus associations with promyelocytic leukemia nuclear bodies using immuno-TRAP. J Cell Biol 201: 325-335.
13. de Thé H, Le Bras M, Lallemand-Breitenbach V. 2012. The cell biology of disease: acute promyelocytic leukemia, arsenic, and PML bodies. J Cell Biol 198: 11-21.
14. Delbarre E, Ivanauskiene K, Kuntziger T, Collas P. 2013. DAXX-dependent supply of soluble (H3.3-H4) dimers to PML bodies pending deposition into chromatin. Genome Res 23: 440-451.
15. Dhayalan A, Tamas R, Bock I, Tattermusch A, Dimitrova E, Kudithipudi S, Ragozin S, Jeltsch A. 2011. The ATRX-ADD domain binds to H3 tail peptides and reads the combined methylation state of K4 and K9. Hum Mol Genet 20: 2195-2203.
16. Dinkel H, Van RK, Michael S, Davey NE, Weatheritt RJ, Born D, Speck T, Kruger D, Grebnev G, Kuban M, et al. 2014. The eukaryotic linear motif resource ELM: 10 years and counting. Nucleic Acids Res 42: D259-D266.
17. Drane P, Ouararhni K, Depaux A, Shuaib M, Hamiche A. 2010. The deathassociated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3. Genes Dev 24: 1253-1265.
18. Elsaesser SJ, Allis CD. 2010. HIRA and Daxx constitute two independent histone H3.3-containing predeposition complexes. Cold Spring Harb Symp Quant Biol 75: 27-34.
19. Eustermann S, Yang JC, Law MJ, Amos R, Chapman LM, Jelinska C, Garrick D, Clynes D, Gibbons RJ, Rhodes D, et al. 2011. Combinatorial readout of histone H3 modifications specifies localization of ATRX to heterochromatin. Nat Struct Mol Biol 18: 777-782.
20. Filipescu D, Szenker E, Almouzni G. 2013. Developmental roles of histone H3 variants and their chaperones. Trends Genet 29: 630-640.
21. Gibbons RJ, Bachoo S, Picketts DJ, Aftimos S, Asenbauer B, Bergoffen J, Berry SA, Dahl N, Fryer A, Keppler K, et al. 1997. Mutations in transcriptional regulator ATRX establish the functional significance of a PHD-like domain. Nat Genet 17: 146-148.
22. Goldberg AD, Banaszynski LA, Noh KM, Lewis PW, Elsaesser SJ, Stadler S, Dewell S, Law M, Guo X, Li X, et al. 2010. Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell 140: 678-691.
23. Gonzalo S, Jaco I, Fraga MF, Chen T, Li E, Esteller M, Blasco MA. 2006. DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol 8: 416-424.
24. Henikoff S. 2008. Nucleosome destabilization in the epigenetic regulation of gene expression. Nat Rev Genet 9: 15-26.
25. Hollenbach AD, McPherson CJ, Mientjes EJ, Iyengar R, Grosveld G. 2002. Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek. J Cell Sci 115: 3319-3330.
26. Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, Kamitani T, Yeh ET, Strauss JF III, Maul GG. 1999. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol 147: 221-234.
27. Iwano T, Tachibana M, Reth M, Shinkai Y. 2004. Importance of TRF1 for functional telomere structure. J Biol Chem 279: 1442-1448.
28. Iwase S, Xiang B, Ghosh S, Ren T, Lewis PW, Cochrane JC, Allis CD, Picketts DJ, Patel DJ, Li H, et al. 2011. ATRX ADD domain links an atypical histone methylation recognition mechanism to human mentalretardation syndrome. Nat Struct Mol Biol 18: 769-776.
29. Jiang WQ, Nguyen A, Cao Y, Chang AC, Reddel RR. 2011. HP1-mediated formation of alternative lengthening of telomeres-associated PML bodies requires HIRA but not ASF1a. PLoS ONE 6: e17036.
30. Kappes F, Burger K, Baack M, Fackelmayer FO, Gruss C. 2001. Subcellular localization of the human proto-oncogene protein DEK. J Biol Chem 276: 26317-26323.
31. Kappes F, Waldmann T, Mathew V, Yu J, Zhang L, Khodadoust MS, Chinnaiyan AM, Luger K, Erhardt S, Schneider R, et al. 2011. The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrity. Genes Dev 25: 673-678.
32. Kavanaugh GM, Wise-Draper TM, Morreale RJ, Morrison MA, Gole B, Schwemberger S, Tichy ED, Lu L, Babcock GF,Wells JM, et al. 2011. The human DEK oncogene regulates DNA damage response signaling and repair. Nucleic Acids Res 39: 7465-7476.
33. Lallemand-Breitenbach V, Zhu J, Puvion F, Koken M, Honore N, Doubeikovsky A, Duprez E, Pandolfi PP, Puvion E, Freemont P, et al. 2001. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor a degradation. J Exp Med 193: 1361-1371.
34. Lewis PW, Elsaesser SJ, Noh KM, Stadler SC, Allis CD. 2010. Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replicationindependent chromatin assembly at telomeres. Proc Natl Acad Sci 107: 14075-14080.
35. Luke B, Lingner J. 2009. TERRA: telomeric repeat-containing RNA. EMBO J 28: 2503-2510.
36. O'Sullivan RJ, Arnoult N, Lackner DH, Oganesian L, Haggblom C, Corpet A, Almouzni G, Karlseder J. 2014. Rapid induction of alternative lengthening of telomeres by depletion of the histone chaperone ASF1. Nat Struct Mol Biol 21: 167-174.
37. Obri A, Ouararhni K, Papin C, Diebold ML, Padmanabhan K, Marek M, Stoll I, Roy L, Reilly PT, Mak TW, et al. 2014. ANP32E is a histone chaperone that removes H2A.Z from chromatin. Nature 505: 648-653.
38. Pchelintsev NA, McBryan T, Rai TS, van Tuyn J, Ray-Gallet D, Almouzni G, Adams PD. 2013. Placing the HIRA histone chaperone complex in the chromatin landscape. Cell Rep 3: 1012-1019.
39. Privette Vinnedge LM, Kappes F, Nassar N,Wells SI. 2013. Stacking the DEK: from chromatin topology to cancer stem cells. Cell Cycle 12: 51-66.
40. Ray-Gallet D,Woolfe A, Vassias I, Pellentz C, Lacoste N, Puri A, Schultz DC, Pchelintsev NA, Adams PD, Jansen LE, et al. 2011. Dynamics of histone H3 deposition in vivo reveal a nucleosome gap-filling mechanism for H3.3 to maintain chromatin integrity. Mol Cell 44: 928-941.
41. Saha AK, Kappes F, Mundade A, Deutzmann A, Rosmarin DM, Legendre M, Chatain N, Al-Obaidi Z, Adams BS, Ploegh HL, et al. 2013. Intercellular trafficking of the nuclear oncoprotein DEK. Proc Natl Acad Sci 110: 6847-6852.
42. Sawatsubashi S,Murata T, LimJ, Fujiki R, Ito S, Suzuki E, Tanabe M, Zhao Y, Kimura S, Fujiyama S, et al. 2010. A histone chaperone, DEK, transcriptionally coactivates a nuclear receptor. Genes Dev 24: 159-170.
43. Schneiderman JI, Orsi GA, Hughes KT, Loppin B, Ahmad K. 2012. Nucleosome-depleted chromatin gaps recruit assembly factors for the H3.3 histone variant. Proc Natl Acad Sci 109: 19721-19726.
44. Sfeir A, Kosiyatrakul ST, Hockemeyer D, MacRae SL, Karlseder J, Schildkraut CL, de Lange T. 2009. Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell 138: 90-103.
45. Sigrist CJ, de Castro E, Cerutti L, Cuche BA, Hulo N, Bridge A, Bougueleret L, Xenarios I. 2013. New and continuing developments at PROSITE. Nucleic Acids Res 41: D344-D347.
46. Szenker E, Ray-Gallet D, Almouzni G. 2011. The double face of the histone variant H3.3. Cell Res 21: 421-434.
47. Tagami H, Ray-Gallet D, Almouzni G, Nakatani Y. 2004. Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways dependent or independent of DNA synthesis. Cell 116: 51-61.
48. Talbert PB, Henikoff S. 2010. Histone variants-ancient wrap artists of the epigenome. Nat Rev Mol Cell Biol 11: 264-275.
49. Waldmann T, Eckerich C, Baack M, Gruss C. 2002. The ubiquitous chromatin protein DEK alters the structure of DNA by introducing positive supercoils. J Biol Chem 277: 24988-24994.
50. Waldmann T, Baack M, Richter N, Gruss C. 2003. Structure-specific binding of the proto-oncogene protein DEK to DNA. Nucleic Acids Res 31: 7003-7010.
51. Waldmann T, Scholten I, Kappes F, Hu HG, Knippers R. 2004. The DEK protein-an abundant and ubiquitous constituent of mammalian chromatin. Gene 343: 1-9.
52. Wong LH, Ren H, Williams E, McGhie J, Ahn S, Sim M, Tam A, Earle E, Anderson MA, Mann J, et al. 2009. Histone H3.3 incorporation provides a unique and functionally essential telomeric chromatin in embryonic stem cells. Genome Res 19: 404-414.
53. Wong LH, McGhie JD, Sim M, Anderson MA, Ahn S, Hannan RD, George AJ, Morgan KA, Mann JR, Choo KH. 2010. ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells. Genome Res 20: 351-360.